Related references
Note: Only part of the references are listed.The radiotherapy quality assurance gap among phase III cancer clinical trials
Kelsey L. Corrigan et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Evidence-Based Planning Target Volume Margin Reduction for Modern Lung Stereotactic Ablative Radiation Therapy Using Deformable Registration
Katie Jasper et al.
ADVANCES IN RADIATION ONCOLOGY (2021)
Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy
Joyce E. Lodeweges et al.
ACTA ONCOLOGICA (2021)
Assessing the Variability and Quality of Lung Stereotactic Radiation Therapy Treatment Plans Using a Web-Based Crowdsourcing Platform
Drew Moghanaki et al.
PRACTICAL RADIATION ONCOLOGY (2020)
Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial
Maud Jaccard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results
Marie Lambrecht et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer
Jihane Boustani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer
Tomas Kron et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial
Anthony M. Brade et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Is stereotactic body radiotherapy for ultra-central lung tumor a feasible option? A systemic review and meta-analysis
Chai Hong Rim et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2018)
The role of dosimetry audit in lung SBRT multi-centre clinical trials
Catharine H. Clark et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2017)
Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial
Anand Swaminath et al.
CLINICAL LUNG CANCER (2017)
Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy
Martha M. Matuszak et al.
PRACTICAL RADIATION ONCOLOGY (2016)
Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy
Yuvnik Trada et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
Gregory M. M. Videtic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Does Quality of Radiation Therapy Predict Outcomes of Multicenter Cooperative Group Trials? A Literature Review
Alysa Fairchild et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
CONSIDERATION OF DOSE LIMITS FOR ORGANS AT RISK OF THORACIC RADIOTHERAPY: ATLAS FOR LUNG, PROXIMAL BRONCHIAL TREE, ESOPHAGUS, SPINAL CORD, RIBS, AND BRACHIAL PLEXUS
Feng-Ming (Spring) Kong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced technology in a multicenter international setting
Damien C. Weber et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
Lester J. Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer
Yukinori Matsuo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame
Y Nagata et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Share Paper
